146 related articles for article (PubMed ID: 34934312)
1. Phenylboronic Acid-Modified Polyamidoamine Mediated the Transfection of Polo-Like Kinase-1 siRNA to Achieve an Anti-Tumor Efficacy.
Gong G; Tang X; Zhang J; Liang X; Yang J; Li Q
Int J Nanomedicine; 2021; 16():8037-8048. PubMed ID: 34934312
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of proliferation and migration of tumor cells through phenylboronic acid-functionalized polyamidoamine-mediated delivery of a therapeutic DNAzyme Dz13.
Yang J; Zhang J; Xing J; Shi Z; Han H; Li Q
Int J Nanomedicine; 2019; 14():6371-6385. PubMed ID: 31496692
[TBL] [Abstract][Full Text] [Related]
3. Phenylboronic acid-modified polyamidoamine-mediated delivery of short GC rich DNA for hepatocarcinoma gene therapy.
Yang J; Zhang J; Liu Y; Shi Z; Han H; Li Q
Biomater Sci; 2019 Aug; 7(8):3348-3358. PubMed ID: 31218303
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery.
Han H; Chen W; Yang J; Liang X; Wang Y; Li Q; Yang Y; Li K
Int J Nanomedicine; 2018; 13():1297-1311. PubMed ID: 29563788
[TBL] [Abstract][Full Text] [Related]
5. Phenylboronic acid-functionalized polyamidoamine-mediated Bcl-2 siRNA delivery for inhibiting the cell proliferation.
Wu D; Yang J; Xing Z; Han H; Wang T; Zhang A; Yang Y; Li Q
Colloids Surf B Biointerfaces; 2016 Oct; 146():318-25. PubMed ID: 27371891
[TBL] [Abstract][Full Text] [Related]
6. Phenylboronic acid-functionalized polyamidoamine-mediated miR-34a delivery for the treatment of gastric cancer.
Song Z; Liang X; Wang Y; Han H; Yang J; Fang X; Li Q
Biomater Sci; 2019 Mar; 7(4):1632-1642. PubMed ID: 30720809
[TBL] [Abstract][Full Text] [Related]
7. Delivery of DNAzyme targeting aurora kinase A to inhibit the proliferation and migration of human prostate cancer.
Xing Z; Gao S; Duan Y; Han H; Li L; Yang Y; Li Q
Int J Nanomedicine; 2015; 10():5715-27. PubMed ID: 26425080
[TBL] [Abstract][Full Text] [Related]
8. Nucleobase-modified polyamidoamine-mediated miR-23b delivery to inhibit the proliferation and migration of lung cancer.
Han H; Yang J; Wang Y; Chen W; Chen J; Yang Y; Li Q
Biomater Sci; 2017 Oct; 5(11):2268-2275. PubMed ID: 28976503
[TBL] [Abstract][Full Text] [Related]
9. Sialic Acid-Targeted Nanovectors with Phenylboronic Acid-Grafted Polyethylenimine Robustly Enhance siRNA-Based Cancer Therapy.
Ji M; Li P; Sheng N; Liu L; Pan H; Wang C; Cai L; Ma Y
ACS Appl Mater Interfaces; 2016 Apr; 8(15):9565-76. PubMed ID: 27007621
[TBL] [Abstract][Full Text] [Related]
10. N-Isopropylacrylamide-modified polyethylenimine-mediated miR-29a delivery to inhibit the proliferation and migration of lung cancer cells.
Xing J; Jia J; Cong X; Liu Z; Li Q
Colloids Surf B Biointerfaces; 2021 Feb; 198():111463. PubMed ID: 33250420
[TBL] [Abstract][Full Text] [Related]
11. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
Wang D; Chang R; Wang G; Hu B; Qiang Y; Chen Z
Anticancer Agents Med Chem; 2017; 17(7):948-954. PubMed ID: 27671301
[TBL] [Abstract][Full Text] [Related]
12. Lipoic Acid-Modified Oligoethyleneimine-Mediated miR-34a Delivery to Achieve the Anti-Tumor Efficacy.
Huang Y; Wang L; Chen Y; Han H; Li Q
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443415
[TBL] [Abstract][Full Text] [Related]
13. [Functions of NET-1 gene in skin squamous cell carcinoma cell line (A431): a siRNA study].
Chen L; Wang JL; Li H; Qin J; Wu YY
Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):691-6. PubMed ID: 20078975
[TBL] [Abstract][Full Text] [Related]
14. A chemoenzymatically synthesized cholesterol-g-poly(amine-co-ester)-mediated
Dong M; Chen J; Zhang J; Liang X; Yang J; Li D; Li Q
Int J Nanomedicine; 2019; 14():1149-1161. PubMed ID: 30863051
[TBL] [Abstract][Full Text] [Related]
15. Effects of cyclin-dependent kinase 8 specific siRNA on the proliferation and apoptosis of colon cancer cells.
He SB; Yuan Y; Wang L; Yu MJ; Zhu YB; Zhu XG
J Exp Clin Cancer Res; 2011 Nov; 30(1):109. PubMed ID: 22104393
[TBL] [Abstract][Full Text] [Related]
16. Chondroitin sulfate-functionalized polyamidoamine as a tumor-targeted carrier for miR-34a delivery.
Chen W; Liu Y; Liang X; Huang Y; Li Q
Acta Biomater; 2017 Jul; 57():238-250. PubMed ID: 28511876
[TBL] [Abstract][Full Text] [Related]
17. Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma.
Shi H; Sun S; Xu H; Zhao Z; Han Z; Jia J; Wu D; Lu J; Liu H; Yu R
Int J Nanomedicine; 2020; 15():3347-3362. PubMed ID: 32494134
[TBL] [Abstract][Full Text] [Related]
18. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
19. A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells.
Li G; Hu Z; Yin H; Zhang Y; Huang X; Wang S; Li W
Int J Nanomedicine; 2013; 8():1293-306. PubMed ID: 23569377
[TBL] [Abstract][Full Text] [Related]
20. Proliferation Potential-Related Protein Promotes the Esophageal Cancer Cell Proliferation, Migration and Suppresses Apoptosis by Mediating the Expression of p53 and Interleukin-17.
Ye F; Song J; Wang Y; Xu X; Zhang K
Pathobiology; 2018; 85(5-6):322-331. PubMed ID: 30223275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
